Federal award
SRISAI BIOPHARMACEUTICAL SOLUTIONS LLC
N3239815P0213
Contract
Obligated and Ceiling
- Obligated (net)
- $72,248.17
- Ceiling (potential value, not spending)
- $72,248.17
- Current value
- $72,248.17
- Gross positive obligations
- $112,229.44
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SRISAI BIOPHARMACEUTICAL SOLUTIONS LLC · DMAXAMHK9XL3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SRISAI BIOPHARMACEUTICAL SOLUTIONS LLC · DMAXAMHK9XL3
- Awarding agency
- Department of War · sub-agency 1700 · office N32398
- Funding agency
- Department of War · sub-agency 1700
- Product or service (PSC)
- AN95 · R&D- MEDICAL: OTHER (OPERATIONAL SYSTEMS DEVELOPMENT)
- Industry (NAICS)
- 493120
- PIID
- N3239815P0213
- Award type code
- B
- Actions
- 4 · Nov 7, 2014 to Jul 8, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 8, 2021 | FY2021 | P00003 | C | −$39,981.27 | — |
| May 13, 2021 | FY2021 | P00002 | K | $0.00 | — |
| Feb 25, 2015 | FY2015 | P00001 | C | $0.00 | — |
| Nov 7, 2014 | FY2015 | 0 | — | $112,229.44 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.